Skip to main content
Vaidya Sane Ayurved Laboratories Limited (NSE:MADHAVBAUG)
India flag India · Delayed Price · Currency is INR
147.00
+6.75 (4.81%)
Nov 12, 2026, 3:29 PM IST

NSE:MADHAVBAUG Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
1,1661,069917.04993.31991.69747.11
Revenue Growth
9.09%16.58%-7.68%0.16%32.74%42.92%
Gross Profit
935.9855.63708.22713.7692.76505.86
Operating Income
28.4992.9119.513.6252.5948.18
Net Income
39.389.8771.3619.848.3334.69
Earnings Per Share
3.768.045.781.574.603.30
EPS Growth
-53.20%39.10%268.15%-65.85%39.32%487.10%

Cash & Debt
Chart
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
342.19230.65157.02183.59155.59191.68
Total Debt
130.2725.8514.7716.781.3410.63
Net Cash (Debt)
211.92204.79142.24166.81154.25181.05
Net Cash Growth
3.48%43.98%-14.73%8.14%-14.80%-
Net Cash Per Share
20.2918.3111.5313.5214.6717.22

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
68.5654.11257.04-12.580.64-131.23
Capital Expenditures
-197.81-78.79-84.47-111.5-69.79-31.72
Free Cash Flow
-129.25-24.67172.56-124.09-69.15-162.95
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
80.25%80.03%77.23%71.85%69.86%67.71%
Operating Margin
2.44%8.69%13.03%1.37%5.30%6.45%
Pretax Margin
3.56%10.11%10.78%2.87%6.49%6.36%
Profit Margin
3.37%8.41%7.78%1.99%4.87%4.64%
FCF Margin
-11.08%-2.31%18.82%-12.49%-6.97%-21.81%

Valuation
Chart
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
39.0719.5013.8192.3751.1259.10
P/FCF Ratio
--5.71---
PS Ratio
1.331.641.071.842.492.74